Items where Author or Contributor is "Hodgson, David"
Up a level |
Number of items: 13.
2024
Hodgson, David;
Wilkins, Neil;
van Leeuwen, Edwin;
Watson, Conall H;
Crofts, Jonathan;
Flasche, Stefan;
Jit, Mark;
Atkins, Katherine E;
(2024)
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination.
The Lancet Regional Health Europe, 38.
100829-.
ISSN 2666-7762
DOI: https://doi.org/10.1016/j.lanepe.2023.100829
Krauer, Fabienne;
Guenther, Felix;
Treskova-Schwarzbach, Marina;
Schoenfeld, Viktoria;
Koltai, Mihaly;
Jit, Mark;
Hodgson, David;
Schneider, Udo;
Wichmann, Ole;
Harder, Thomas;
+2 more...
Sandmann, Frank G;
Flasche, Stefan;
(2024)
Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study.
BMC medicine, 22 (1).
478-.
ISSN 1741-7015
DOI: https://doi.org/10.1186/s12916-024-03687-3
Russell, Timothy W;
Townsley, Hermaleigh;
Hellewell, Joel;
Gahir, Joshua;
Shawe-Taylor, Marianne;
Greenwood, David;
Hodgson, David;
Hobbs, Agnieszka;
Dowgier, Giulia;
Penn, Rebecca;
+34 more...
Sanderson, Theo;
Stevenson-Leggett, Phoebe;
Bazire, James;
Harvey, Ruth;
Fowler, Ashley S;
Miah, Murad;
Smith, Callie;
Miranda, Mauro;
Bawumia, Philip;
Mears, Harriet V;
Adams, Lorin;
Hatipoglu, Emine;
O'Reilly, Nicola;
Warchal, Scott;
Ambrose, Karen;
Strange, Amy;
Kelly, Gavin;
Kjar, Svend;
Papineni, Padmasayee;
Corrah, Tumena;
Gilson, Richard;
Libri, Vincenzo;
Kassiotis, George;
Gamblin, Steve;
Lewis, Nicola S;
Williams, Bryan;
Swanton, Charles;
Gandhi, Sonia;
Beale, Rupert;
Wu, Mary Y;
Bauer, David LV;
Carr, Edward J;
Wall, Emma C;
Kucharski, Adam J;
(2024)
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.
The Lancet. Infectious diseases.
ISSN 1473-3099
DOI: https://doi.org/10.1016/S1473-3099(24)00484-5
2023
Atkins, Katherine E;
Hodgson, David;
(2023)
Vaccination of Older Adults Against Respiratory Syncytial Virus: The Final Pieces of the Puzzle.
Clinical infectious diseases, 77 (3).
pp. 490-491.
ISSN 1058-4838
DOI: https://doi.org/10.1093/cid/ciad162
2022
Colton, Hayley;
Hodgson, David;
Hornsby, Hailey;
Brown, Rebecca;
Mckenzie, Joanne;
Bradley, Kirsty L;
James, Cameron;
Lindsey, Benjamin B;
Birch, Sarah;
Marsh, Louise;
+14 more...
Wood, Steven;
Bayley, Martin;
Dickson, Gary;
James, David C;
Nicklin, Martin J;
Sayers, Jon R;
Zafred, Domen;
Rowland-Jones, Sarah L;
Kudesia, Goura;
Kucharski, Adam;
CMMID COVID-19 Working Group;
Darton, Thomas C;
de Silva, Thushan I;
Collini, Paul J;
(2022)
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.
Wellcome Open Research, 6.
220-.
ISSN 2398-502X
DOI: https://doi.org/10.12688/wellcomeopenres.17143.3
Hodgson, David;
Koltai, Mihaly;
Krauer, Fabienne;
Flasche, Stefan;
Jit, Mark;
Atkins, Katherine E;
(2022)
Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales.
Vaccine, 40 (49).
pp. 7151-7157.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2022.10.041
Koltai, Mihaly;
Krauer, Fabienne;
Hodgson, David;
van Leeuwen, Edwin;
Treskova-Schwarzbach, Marina;
Jit, Mark;
Flasche, Stefan;
(2022)
Determinants of RSV epidemiology following suppression through pandemic contact restrictions.
Epidemics, 40.
100614-.
ISSN 1755-4365
DOI: https://doi.org/10.1016/j.epidem.2022.100614
Li, Xiao;
Hodgson, David;
Flaig, Julien;
Kieffer, Alexia;
Herring, William L;
Beyhaghi, Hadi;
Willem, Lander;
Jit, Mark;
Bilcke, Joke;
Beutels, Philippe;
+1 more...
REspiratory Syncytial virus Consortium in EUrope (RESCEU) Invest;
(2022)
Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study.
Value in health, 26 (4).
pp. 508-518.
ISSN 1098-3015
DOI: https://doi.org/10.1016/j.jval.2022.11.014
2021
Hodgson, David;
Flasche, Stefan;
Jit, Mark;
Kucharski, Adam J;
CMMID COVID-19 Working Group;
Centre for Mathematical Modelling of Infectious Disease (CMMID);
(2021)
The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant.
Eurosurveillance, 26 (20).
ISSN 1025-496X
DOI: https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428
Li, You;
Hodgson, David;
Wang, Xin;
Atkins, Katherine E;
Feikin, Daniel R;
Nair, Harish;
(2021)
Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study.
The Lancet. Infectious diseases, 21 (9).
pp. 1303-1312.
ISSN 1473-3099
DOI: https://doi.org/10.1016/S1473-3099(20)30703-9
2020
Hodgson, David;
Pebody, Richard;
Panovska-Griffiths, Jasmina;
Baguelin, Marc;
Atkins, Katherine E;
(2020)
Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis.
BMC MEDICINE, 18 (1).
348-.
ISSN 1741-7015
DOI: https://doi.org/10.1186/s12916-020-01802-8
2019
Hodgson, David;
Atkins, Katherine E;
Baguelin, Marc;
Panovska-Griffiths, Jasmina;
Thorrington, Dominic;
van Hoek, Albert Jan;
Zhao, Hongxin;
Fragaszy, Ellen;
Hayward, Andrew C;
Pebody, Richard;
(2019)
Estimates for quality of life loss due to Respiratory Syncytial Virus.
Influenza Other Respir Viruses, 14 (1).
pp. 19-27.
ISSN 1750-2640
DOI: https://doi.org/10.1111/irv.12686
2017
Hodgson, David;
Baguelin, Marc;
van Leeuwen, Edwin;
Panovska-Griffiths, Jasmina;
Ramsay, Mary;
Pebody, Richard;
Atkins, Katherine E;
(2017)
Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis.
The lancet Public health, 2 (2).
e74-e81.
ISSN 2468-2667
DOI: https://doi.org/10.1016/S2468-2667(16)30044-5